FDA NDC Directory · JSON-LD · Markdown

Ultramicrosize Griseofulvin

NDC 0781-5828 · HUMAN PRESCRIPTION DRUG · TABLET, COATED

Labeler / ManufacturerSandoz Inc
Marketing categoryAbbreviated NDA (generic) · App ANDA202805
Dosage form / routeTABLET, COATED · ORAL
Active ingredientsGRISEOFULVIN (250 mg/1)
Marketing started20200401
Package count2

External sources

Source: openFDA. Public-domain (CC0).